Home › Cancro del colon › Maryland › Baltimore
Studi clinici su Cancro del colon a Baltimore, MD
13 studi su Cancro del colon cercano partecipanti presso sedi a Baltimore e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Family Communications After Genetic Testing
In reclutamentoVolontari sani benvenuti
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · a 8 mi di distanza
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
In reclutamentoFase 3
- University of Maryland ( Site 2016), Baltimore
- Greater Baltimore Medical Center ( Site 0068), Baltimore
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
In reclutamentoFase 3
- Greater Baltimore Medical Center, Baltimore
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
In reclutamentoFase 3
- Saint Agnes Hospital, Baltimore
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
In reclutamentoFase 2
- University of Maryland Greenbaum, Baltimore
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
In reclutamento
- Kaiser Permanente-Woodlawn Medical Center, Baltimore
- Kaiser Permanente Lutherville - Timonium Medical Center, Lutherville · a 9 mi di distanza
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
In reclutamentoFase 2/3
- Greater Baltimore Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Saint Agnes Hospital, Baltimore
- e altri 6
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
In reclutamentoFase 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
EXoPERT EMERALD Clinical Study
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- John Hopkins University, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
In reclutamentoFase 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · a 9 mi di distanza
- United Theranostics - Chesapeake, Glen Burnie · a 9 mi di distanza
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
In reclutamentoFase 1
- Johns Hopkins University, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
In reclutamentoFase 1/2
- Johns Hopkins University, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · a 8 mi di distanza
Studi su Cancro del colon in altre città
- Boston, MA22 studi
- New York City, NY22 studi
- Houston, TX20 studi
- Los Angeles, CA16 studi
- Nashville, TN16 studi
- St. Louis, MO15 studi
- Arlington, VA15 studi
- Chicago, IL14 studi
- San Antonio, TX14 studi
- Baldwin Park, CA14 studi
- Tampa, FL13 studi
- Washington, DC12 studi
Altri studi a Baltimore
- Cancro del polmone non a piccole cellule60 studi
- Cancro al seno47 studi
- Cancro alla prostata43 studi
- Cancro ai polmoni40 studi
- Cancro (tutti i tipi)37 studi
- Cancro pancreatico31 studi
- Cancro colorettale31 studi
- Cancro metastatico28 studi
- Obesità26 studi
- Cancro della vescica24 studi
- Insufficienza cardiaca24 studi
- Cancro ovarico22 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.